Ivanka Tsakovska
Ivanka Tsakovska
Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences
Verified email at biomed.bas.bg
TitleCited byYear
The role of the European Chemicals Bureau in promoting the regulatory use of (Q) SAR methods
AP Worth, A Bassan, J De Bruijn, A Gallegos Saliner, T Netzeva, M Pavan, ...
SAR and QSAR in Environmental Research 18 (1-2), 111-125, 2007
1302007
The characterisation of (quantitative) structure-activity relationships: preliminary guidance
AP Worth, A Bassan, A Gallegos, TI Netzeva, G Patlewicz, M Pavan, ...
Institute for Health and Consumer Protection, Toxicology and Chemical …, 2005
802005
Interactions of poly (vinylpyrrolidone) with ibuprofen and naproxen: experimental and modeling studies
S Bogdanova, I Pajeva, P Nikolova, I Tsakovska, B Müller
Pharmaceutical research 22 (5), 806-815, 2005
692005
Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens
R Benigni, C Bossa, T Netzeva, A Rodomonte, I Tsakovska
Environmental and molecular mutagenesis 48 (9), 754-771, 2007
682007
A mini review of mammalian toxicity (Q) SAR models
I Tsakovska, I Lessigiarska, T Netzeva, AP Worth
QSAR & Combinatorial Science 27 (1), 41-48, 2008
562008
Computational studies of free radical-scavenging properties of phenolic compounds
P Alov, I Tsakovska, I Pajeva
Current topics in medicinal chemistry 15 (2), 85-104, 2015
482015
Validation of counter propagation neural network models for predictive toxicology according to the OECD principles: a case study
M Vračko, V Bandelj, P Barbieri, E Benfenati, Q Chaudhry, M Cronin, ...
SAR and QSAR in Environmental Research 17 (3), 265-284, 2006
462006
QSAR and 3D-QSAR of phenothiazine type multidrug resistance modulators in P388/ADR cells
IM Tsakovska
Bioorganic & medicinal chemistry 11 (13), 2889-2899, 2003
322003
Molecular modelling study of the PPARγ receptor in relation to the mode of action/adverse outcome pathway framework for liver steatosis
I Tsakovska, M Al Sharif, P Alov, A Diukendjieva, E Fioravanzo, ...
International journal of molecular sciences 15 (5), 7651-7666, 2014
302014
Modes-of-action related to repeated dose toxicity: Tissue-specific biological roles of PPARγ ligand-dependent dysregulation in nonalcoholic fatty liver disease
M Al Sharif, P Alov, V Vitcheva, I Pajeva, I Tsakovska
PPAR research 2014, 2014
222014
Evaluation of SARs for the prediction of skin irritation/corrosion potential–structural inclusion rules in the BfR decision support system
A Gallegos Saliner, I Tsakovska, M Pavan, G Patlewicz, AP Worth
SAR and QSAR in Environmental Research 18 (3-4), 331-342, 2007
222007
Quantitative structure-skin permeability relationships
I Tsakovska, I Pajeva, M Al Sharif, P Alov, E Fioravanzo, S Kovarich, ...
Toxicology 387, 27-42, 2017
212017
Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance
I Tsakovska, I Pajeva
Current drug targets 7 (9), 1123-1134, 2006
212006
Evaluation of SARs for the prediction of eye irritation/corrosion potential–structural inclusion rules in the BfR decision support system
I Tsakovska, AG Saliner, T Netzeva, M Pavan, AP Worth
SAR and QSAR in Environmental Research 18 (3-4), 221-235, 2007
182007
The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation
M Al Sharif, I Tsakovska, I Pajeva, P Alov, E Fioravanzo, A Bassan, ...
Toxicology 392, 140-154, 2017
142017
Recent advances in the molecular modeling of estrogen receptor-mediated toxicity
I Tsakovska, I Pajeva, P Alov, A Worth
Advances in protein chemistry and structural biology 85, 217-251, 2011
142011
Structural and dynamical insight into PPARγ antagonism: in silico study of the ligand-receptor interactions of non-covalent antagonists
F Fratev, I Tsakovska, M Al Sharif, E Mihaylova, I Pajeva
International journal of molecular sciences 16 (7), 15405-15424, 2015
122015
Review of (Q) SARs for mammalian toxicity
I Tsakovska, I Lessigiarska, T Netzeva, A Worth
JRC report EUR 22846, 2006
112006
Molecular modeling of P-glycoprotein and related drugs
I Pajeva, C Globisch, R Fleischer, I Tsakovska, M Wiese
Medicinal Chemistry Research 2 (14), 106-117, 2005
112005
Molecular dynamics simulation of the human estrogen receptor alpha: contribution to the pharmacophore of the agonists
D Jereva, F Fratev, I Tsakovska, P Alov, T Pencheva, I Pajeva
Mathematics and Computers in Simulation 133, 124-134, 2017
82017
The system can't perform the operation now. Try again later.
Articles 1–20